Jong Senfang has found 22 "super virus" patients in the same hospital within 3 months-a data that may explain why the "super virus" is making waves around the world. According to the Times of India, in Hinduja Hospital in Mumbai, India, a total of 22 patients with "super virus" were found within 3 months. At the same time, in the fourth largest city of Chennai in India, 44 patients have been identified and Haryana has identified 26 patients. Globally, the UK has identified 37, and now India, Pakistan, the United States, Canada, Sweden, Greece, Israel, the Netherlands, the United Kingdom and Brazil have found "super virus" infected people. It is reported that 170 people have been infected globally, which is a trend that has spread around the world. What is "Super virus"? A report published jointly by the University of Cardiff, the British Health Protection Agency and medical researchers at the University of Madras in India shows that "Super virus" is named NDM-1, full name New Delhi metallo-s-lactamase-1, which was found in India and Pakistan, is a "super germ" that can almost withstand all antibiotics. The virus is spreading through patients who have been treated in these countries, especially those who have undergone cosmetic surgery in these countries. The UK's Health Protection Agency (NDM-1) reports that the bacteria are highly resistant to almost all antibiotics and that so far no way has been found to ensure that the virus is killed. The research director, Cardiff University expert Walsh, said the infected were treated in India and Pakistan, and that the virus could become a global problem as people look for cheap medical care, especially cosmetic surgery. "The ' super virus ' is likely to spread rapidly among different countries by air travel and human migration." "The researchers said. But the president of the Indian Medical Biology Association, Mr Farhad, argues that Europe's conclusion that the "Super virus" originated in the South Asian continent has not been definitively confirmed. "Some of [Europe's], published in the Journal of the Lancet, is not appropriate." "he said.
The content source of this page is from Internet, which doesn't represent Alibaba Cloud's opinion;
products and services mentioned on that page don't have any relationship with Alibaba Cloud. If the
content of the page makes you feel confusing, please write us an email, we will handle the problem
within 5 days after receiving your email.
If you find any instances of plagiarism from the community, please send an email to:
info-contact@alibabacloud.com
and provide relevant evidence. A staff member will contact you within 5 working days.